Own and drive the end-to-end CMC strategy across development, clinical supply, scale-up, and commercialization for a portfolio of small-molecule programs.
Operate with a high degree of independence and accountability, proactively identifying risks, tradeoffs, and opportunities across the CMC landscape.
Build scalable CMC roadmaps aligned with clinical milestones, financing events, and long-term corporate strategy.

Development, Manufacturing & Supply:

Ensure reliable preclinical, clinical and future commercial supply of safe, high-quality drug products and lead development of manufacturing strategies to ensure capacity for the product portfolio.
Provide senior technical oversight of process development, manufacturing, analytical development, and control strategies
Work collaboratively with Quality and Regulatory to ensure robust, phase-appropriate CMC execution that supports Phase 1 through Phase 3 and commercial readiness

Regulatory & Compliance:

Oversee global CMC regulatory strategy, ensuring alignment with FDA, EMA, and other regulatory authorities.
Oversee preparation, review, and approval of all CMC-related sections of INDs, NDAs, amendments, and variations
Oversee CMC related regulatory interactions, inspections, and agency meetings

Faeth Therapeutics

Faeth Therapeutics is a clinical-stage oncology company listed on Nasdaq that recently raised $200M in funding. They are a small, focused team where every person has direct impact — united by a shared commitment to care deeply, create boldly, and never stop learning.

Apply for This Position